Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
QLGNCompany Name
QUALIGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQQUALIGEN THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
QLGN - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ -1.65M | $ -7.01M | 0% |
| 3/31/2025 | $ 33.13K | $ -6.9M | -20825.13% |
| 12/31/2024 | $ 2.68M | $ -6.35M | -236.91% |
| 9/30/2024 | $ -2.14M | $ -7.94M | 0% |
| 6/30/2024 | $ -4.28M | $ -9.78M | 0% |
| 3/31/2024 | $ -3.52M | $ -11.66M | 0% |
| 12/31/2023 | $ -2.1M | $ -13.42M | 0% |
| 9/30/2023 | $ -1.64M | $ -17.34M | 0% |
| 6/30/2023 | $ 2.03M | $ -17.51M | -860.72% |
| 3/31/2023 | $ 4.87M | $ -18.17M | -373.08% |
Key Performance Insights, Last 5 Years
- QUALIGEN THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, QUALIGEN THERAPEUTICS INC's average ROE has been -1803.53%.
- The median ROE for QUALIGEN THERAPEUTICS INC during this period was -143.06%
- QUALIGEN THERAPEUTICS INC reached its highest ROE over the past 5 years at -43.25%.
- The lowest ROE recorded by QUALIGEN THERAPEUTICS INC in the same timeframe -20825.13%
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for QUALIGEN THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -28.8M ] / Equity [ $ -2.89M ]
(=) ROE [ 0% ] QLGN - Return on Equity, Last 5 years
-20825.13%
Minimum
Mar 31, 2025
-43.25%
Maximum
Sep 30, 2021
-1803.53%
Average
-143.06%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |